| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |